You will all have heard a lot about Pfizer’s offers to buy AstraZeneca, and many people have asked me what this might mean for the School and for the Campus. I’m afraid that I don’t think it’s a cause for celebration. Over the last year or so I have thoroughly enjoyed working with senior people […]
Did you know?
Due to the unique qualities of mobile devices, ie their ability to store personal data, capture high quality images and the fact that they are generally always switched on, there is a lot of interest in producing software (apps) on these devices for medical purposes. Researchers need to be aware that if an app is produced […]
Senior Academic Promotions (SAP): Open Forum Sessions
Hosted by the Pro Vice-Chancellor for Institutional Affairs, Professor Jeremy Sanders, the first session on 8th May (repeated on 16th July) will provide an overview of the University’s Senior Academic Promotions (SAP) procedure, highlight the main changes to the process, provide an overview of the SAP CV Scheme and address some of the common misconceptions surrounding SAP. There is also an […]
New Head of Research Communications to help with Clinical School’s Media Relations
Craig Brierley has joined the University’s Office of Communications and External Affairs as Head of Research Communications. Craig was previously Media Relations Manager at the Wellcome Trust, where he helped achieve widespread coverage for stories on everything from the rise of drug-resistant strains of malaria through to the development of new IVF techniques to prevent […]
Wellcome Trust Successes
The Clinical School is pleased to announce several successes in recent applications for Wellcome Trust funding. Professor Gillian Griffiths and Professor Margaret ‘Scottie’ Robinson, both based in CIMR, have had their Principal Research Fellowships renewed. Dr James Rowe (Clinical Neurosciences) has had his Senior Research Fellowship renewed. Finally, Professor Ed Bullmore and his team have […]
Message from the Regius |May 9 2014
You will all have heard a lot about Pfizer’s offers to buy AstraZeneca, and many people have asked me what this might mean for the School and for the Campus. I’m afraid that I don’t think it’s a cause for celebration. Over the last year or so I have thoroughly enjoyed working with senior people […]
